Juniper Pharma (JNP) Announces Publication of Data from Two COL-1077 Phase 1s; Plans to Report Topline Data in Q3
Tweet Send to a Friend
Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) announced that the international peer-reviewed medical journal Clinical Pharmacology in Drug Development has published the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE